Characterization of NeuN expression in the mouse neuronal NSC-34 cell line using RT-qPCR, immunological staining and siRNA-mediated gene suppression

Background: Acute spinal trauma is followed by a secondary injury that causes additional damage to the tissue. The mouse neuronal hybrid cell line NSC-34 is planned for studies regarding this process, wherefore the cell line needed to be established in the laboratory and a proof-of-concept study nee...

Full description

Bibliographic Details
Main Author: Hallgren, Henrik
Format: Others
Language:English
Published: Uppsala universitet, Institutionen för kvinnors och barns hälsa 2019
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-389757
id ndltd-UPSALLA1-oai-DiVA.org-uu-389757
record_format oai_dc
spelling ndltd-UPSALLA1-oai-DiVA.org-uu-3897572019-08-22T04:54:04ZCharacterization of NeuN expression in the mouse neuronal NSC-34 cell line using RT-qPCR, immunological staining and siRNA-mediated gene suppressionengHallgren, HenrikUppsala universitet, Institutionen för kvinnors och barns hälsa2019Rbfox-3Neuronal Nucleusmotor neurondifferentiationsecondary injuryBiomedical Laboratory Science/TechnologyBiomedicinsk laboratorievetenskap/teknologiBackground: Acute spinal trauma is followed by a secondary injury that causes additional damage to the tissue. The mouse neuronal hybrid cell line NSC-34 is planned for studies regarding this process, wherefore the cell line needed to be established in the laboratory and a proof-of-concept study needed to be performed. A suitable target gene for this study was Neuronal Nucleus (NeuN), a neuronal marker expressed in nearly all neuronal cells although not yet studied in NSC-34. Aim: The aim of this project was to characterize the expression of NeuN in differentiated and undifferentiated NSC-34 cells and silence gene expression by using siRNA. Methods: RT-qPCR was used to measure NeuN expression during passages 5 to 15 and a comparison was performed between one early and one late passage. Lipofectamine® RNAiMAX was used for siRNA-treatment in different concentrations and several different medium compositions were tested as differentiation media. Results: NeuN was expressed in passages 5 to 15, with decreased expression levels in passage 13 (ΔCt 15.36 ± 0.16) compared to passage 5 (ΔCt 15.09 ± 0.16), p < 0.05. The expression levels did not change after differentiation. siRNA-treatment yielded knockdown when using  high concentrations of the reagent (p < 0.05). Conclusion: NeuN was expressed in a stable, low level throughout passages 5 to 15 with a slightly decreased expression during later passages and no change after differentiation. The siRNA-treatment suppressed gene expression, although further optimization is needed to increase the suppression. Student thesisinfo:eu-repo/semantics/bachelorThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-389757application/pdfinfo:eu-repo/semantics/openAccess
collection NDLTD
language English
format Others
sources NDLTD
topic Rbfox-3
Neuronal Nucleus
motor neuron
differentiation
secondary injury
Biomedical Laboratory Science/Technology
Biomedicinsk laboratorievetenskap/teknologi
spellingShingle Rbfox-3
Neuronal Nucleus
motor neuron
differentiation
secondary injury
Biomedical Laboratory Science/Technology
Biomedicinsk laboratorievetenskap/teknologi
Hallgren, Henrik
Characterization of NeuN expression in the mouse neuronal NSC-34 cell line using RT-qPCR, immunological staining and siRNA-mediated gene suppression
description Background: Acute spinal trauma is followed by a secondary injury that causes additional damage to the tissue. The mouse neuronal hybrid cell line NSC-34 is planned for studies regarding this process, wherefore the cell line needed to be established in the laboratory and a proof-of-concept study needed to be performed. A suitable target gene for this study was Neuronal Nucleus (NeuN), a neuronal marker expressed in nearly all neuronal cells although not yet studied in NSC-34. Aim: The aim of this project was to characterize the expression of NeuN in differentiated and undifferentiated NSC-34 cells and silence gene expression by using siRNA. Methods: RT-qPCR was used to measure NeuN expression during passages 5 to 15 and a comparison was performed between one early and one late passage. Lipofectamine® RNAiMAX was used for siRNA-treatment in different concentrations and several different medium compositions were tested as differentiation media. Results: NeuN was expressed in passages 5 to 15, with decreased expression levels in passage 13 (ΔCt 15.36 ± 0.16) compared to passage 5 (ΔCt 15.09 ± 0.16), p < 0.05. The expression levels did not change after differentiation. siRNA-treatment yielded knockdown when using  high concentrations of the reagent (p < 0.05). Conclusion: NeuN was expressed in a stable, low level throughout passages 5 to 15 with a slightly decreased expression during later passages and no change after differentiation. The siRNA-treatment suppressed gene expression, although further optimization is needed to increase the suppression.
author Hallgren, Henrik
author_facet Hallgren, Henrik
author_sort Hallgren, Henrik
title Characterization of NeuN expression in the mouse neuronal NSC-34 cell line using RT-qPCR, immunological staining and siRNA-mediated gene suppression
title_short Characterization of NeuN expression in the mouse neuronal NSC-34 cell line using RT-qPCR, immunological staining and siRNA-mediated gene suppression
title_full Characterization of NeuN expression in the mouse neuronal NSC-34 cell line using RT-qPCR, immunological staining and siRNA-mediated gene suppression
title_fullStr Characterization of NeuN expression in the mouse neuronal NSC-34 cell line using RT-qPCR, immunological staining and siRNA-mediated gene suppression
title_full_unstemmed Characterization of NeuN expression in the mouse neuronal NSC-34 cell line using RT-qPCR, immunological staining and siRNA-mediated gene suppression
title_sort characterization of neun expression in the mouse neuronal nsc-34 cell line using rt-qpcr, immunological staining and sirna-mediated gene suppression
publisher Uppsala universitet, Institutionen för kvinnors och barns hälsa
publishDate 2019
url http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-389757
work_keys_str_mv AT hallgrenhenrik characterizationofneunexpressioninthemouseneuronalnsc34celllineusingrtqpcrimmunologicalstainingandsirnamediatedgenesuppression
_version_ 1719236695882203136